Mehlman weighs the social and economic costs of the many proposals to regulate or limit genetic engineering and provides six concrete policy recommendations-from professional licensing to a ban on germ-line enhancement-that propose to make the future of genetic enhancement more equitable and safe.
Mehlman weighs the social and economic costs of the many proposals to regulate or limit genetic engineering and provides six concrete policy recommendations-from professional licensing to a ban on germ-line enhancement-that propose to make the future of genetic enhancement more equitable and safe.
Maxwell J. Mehlman is Arthur E. Petersilge Professor of Law and Director of the Law-Medicine Center, Case Western Reserve University School of Law, and Professor of Biomedical Ethics at the Case Western Reserve University School of Medicine. He is co-author of Access to the Genome: The Challenge to Equality and co-editor of the Encyclopedia of Ethical, Legal and Policy Issues in Biotechnology. He lives in Cleveland, Ohio.
Inhaltsangabe
Preliminary Table of Contents: Acknowledgments Introduction 1. An Announcement at the White House 2. Scientific Foundations 3. Four Revolutions 4. The Fifth Revolution 5. Safety and Effectiveness 6. Autonomy 7. Authenticity 8. Access 9. Inequality and Unfairness 10. Hubris 11. Solutions 12. Better Solutions 13. Spotting Enhancement 14. Conclusion Notes Index
Preliminary Table of Contents: Acknowledgments Introduction 1. An Announcement at the White House 2. Scientific Foundations 3. Four Revolutions 4. The Fifth Revolution 5. Safety and Effectiveness 6. Autonomy 7. Authenticity 8. Access 9. Inequality and Unfairness 10. Hubris 11. Solutions 12. Better Solutions 13. Spotting Enhancement 14. Conclusion Notes Index
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309